Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Phase I Safety and Immunogenicity Study of HIV p17/p24:Ty-VLP in HIV-1 Seronegative Subjects

National Institute of Allergy and Infectious Diseases (NIAID)
ClinicalTrials.gov · Datasets · License: Public Domain
Open Source ↗
hiv-1hiv-infectionssyntheticvaccines
hiv infections, vaccines, synthetic, recombinant proteins, hiv-1, aids vaccines, hiv core protein p24, p24-vlp vaccine, gene products, gag, hiv seronegativity, hiv preventive vaccine, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 806023
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.